Fundz

Garuda Therapeutics Appoints Giorgia Scapin, Ph.D., as Chief Scientific Officer | Citybiz

PRIVATEJul 12, 2023

Company

Garuda Therapeutics

CambridgeBiotechnologyHealth CareScience And Engineering

Description

CAMBRIDGE, Mass.–– Garuda Therapeutics , a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer. Transitioning from her previous role as Senior Vice President of Research and Development at Garuda, Dr. Scapin will oversee the company’s scientific strategy and lead the advancement of Garuda’s off-the-shelf hematopoietic stem cell therapies in her new role as Chief Scientific Officer.

Quick answer

Garuda Therapeutics Appoints Giorgia Scapin, Ph.D., as Chief Scientific Officer | Citybiz (July 12, 2023). Garuda Therapeutics is based in Cambridge, Massachusetts, United States.

What did Garuda Therapeutics announce on July 12, 2023?
CAMBRIDGE, Mass.–– Garuda Therapeutics , a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer. Transitioning from her previous role as Senior Vice President of Research and Development at Garuda, Dr. Scapin will oversee the company’s scientific strategy and lead the advancement of Garuda’s...
What does Garuda Therapeutics do?
Garuda Therapeutics seeks to eliminate the need for stem cell donors for blood stem cell transplants.
Where is Garuda Therapeutics based?
Garuda Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Atavistik Bio (July 17, 2023), Triumvira Immunologics Inc. (July 20, 2023), Koneksa Health (June 27, 2023) and Viracta Therapeutics (August 7, 2023) also announced leadership changes within 45 days of Garuda Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Garuda Therapeutics, and when

A new leader at Garuda Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Garuda Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Garuda Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Garuda Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Garuda Therapeutics

Location

215 First Street

Cambridge, Massachusetts, United States

About

Garuda Therapeutics seeks to eliminate the need for stem cell donors for blood stem cell transplants. Garuda’s proprietary off-the-shelf hematopoietic stem cell (HSC) therapies enable self-renewing, HLA compatible and transgene-free HSCs, available immediately for patients. An immediately available, off-the-shelf option for patients could provide much needed strategies in a multitude of blood disorders across oncology, autoimmune indications, rare heme disorders and inborn errors of metabolism by effectively resetting bone marrow function.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Garuda Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Avanish
Likely contact at this company
••••••••@••••••••

See Avanish's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Garuda Therapeutics's next move

Learn about Strategic plan

Garuda Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.